Company Filing History:
Years Active: 2000
Title: Juan Antonio Crespo: Innovator in Vaccine Development
Introduction
Juan Antonio Crespo is a notable inventor based in Naucalpan, Mexico. He has made significant contributions to the field of vaccine development, particularly in relation to Bordetella pertussis, the bacterium responsible for whooping cough. With a total of 2 patents to his name, Crespo's work is pivotal in advancing immunological research and public health.
Latest Patents
Crespo's latest patents focus on antigenic preparations derived from Bordetella pertussis. The first patent describes a method of deriving an antigen characterized by a relative molecular weight of about 67,000 to 73,000, as determined by 12% (w/w) polyacrylamide gel electrophoresis. This method involves culturing Bordetella pertussis cells, treating the culture to obtain an outer membrane fraction, and isolating the antigen from this fraction. The second patent provides a vaccine containing a proteinaceous material derived from the outer membrane of Bordetella pertussis. This material is characterized by a similar molecular weight and is designed to induce an immune response in individuals when administered.
Career Highlights
Crespo is currently associated with Medeva Pharma Limited, where he continues to innovate in the field of vaccine research. His work has been instrumental in developing effective immunological solutions that address public health challenges.
Collaborations
Crespo has collaborated with notable colleagues, including Juraj Ivanyi and Pavel Novotny, who have contributed to his research endeavors. Their combined expertise has enhanced the development of his patented technologies.
Conclusion
Juan Antonio Crespo's contributions to vaccine development, particularly through his patents related to Bordetella pertussis, highlight his role as an influential inventor in the field. His work not only advances scientific knowledge but also plays a crucial role in improving public health outcomes.